Katamaran Capital LLP Purchases New Position in Synopsys, Inc. $SNPS

Katamaran Capital LLP purchased a new stake in shares of Synopsys, Inc. (NASDAQ:SNPS) during the third quarter, Holdings Channel reports. The fund purchased 3,859 shares of the semiconductor company’s stock, valued at approximately $1,904,000. Synopsys accounts for approximately 1.7% of Katamaran Capital LLP’s investment portfolio, making the stock its 22nd largest position.

Other hedge funds have also recently bought and sold shares of the company. Lionshead Wealth Management LLC increased its holdings in Synopsys by 1.9% in the 2nd quarter. Lionshead Wealth Management LLC now owns 914 shares of the semiconductor company’s stock valued at $469,000 after buying an additional 17 shares during the period. YANKCOM Partnership increased its position in Synopsys by 3.3% in the 2nd quarter. YANKCOM Partnership now owns 537 shares of the semiconductor company’s stock valued at $275,000 after acquiring an additional 17 shares in the last quarter. Manchester Capital Management LLC raised its stake in shares of Synopsys by 5.3% in the second quarter. Manchester Capital Management LLC now owns 340 shares of the semiconductor company’s stock worth $174,000 after acquiring an additional 17 shares during the last quarter. Concord Asset Management LLC VA lifted its position in shares of Synopsys by 0.8% during the second quarter. Concord Asset Management LLC VA now owns 2,379 shares of the semiconductor company’s stock worth $1,220,000 after purchasing an additional 18 shares in the last quarter. Finally, Rehmann Capital Advisory Group grew its stake in shares of Synopsys by 1.4% during the second quarter. Rehmann Capital Advisory Group now owns 1,345 shares of the semiconductor company’s stock valued at $690,000 after purchasing an additional 18 shares during the last quarter. 85.47% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, insider Janet Lee sold 250 shares of the stock in a transaction on Monday, January 12th. The stock was sold at an average price of $530.00, for a total value of $132,500.00. Following the sale, the insider owned 11,959 shares in the company, valued at approximately $6,338,270. This represents a 2.05% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Shelagh Glaser sold 3,657 shares of the company’s stock in a transaction on Friday, December 19th. The shares were sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the completion of the transaction, the chief financial officer owned 17,842 shares in the company, valued at approximately $8,221,058.34. This represents a 17.01% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 4,157 shares of company stock worth $1,945,036 over the last three months. 0.62% of the stock is owned by insiders.

Synopsys Price Performance

NASDAQ SNPS opened at $438.90 on Tuesday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.52 and a current ratio of 1.62. Synopsys, Inc. has a 52-week low of $365.74 and a 52-week high of $651.73. The business has a 50 day simple moving average of $479.34 and a 200 day simple moving average of $493.86. The stock has a market cap of $83.97 billion, a price-to-earnings ratio of 54.93, a PEG ratio of 3.56 and a beta of 1.12.

Synopsys (NASDAQ:SNPS) last posted its quarterly earnings data on Wednesday, December 10th. The semiconductor company reported $2.90 EPS for the quarter, beating the consensus estimate of $2.79 by $0.11. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. The business had revenue of $2.25 billion for the quarter, compared to analysts’ expectations of $2.25 billion. During the same period in the previous year, the firm posted $3.40 EPS. The firm’s revenue was up 37.8% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. Analysts anticipate that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts have commented on SNPS shares. KeyCorp increased their price objective on Synopsys from $575.00 to $600.00 and gave the company an “overweight” rating in a research report on Thursday, December 11th. Zacks Research raised Synopsys from a “strong sell” rating to a “hold” rating in a report on Monday, November 10th. Morgan Stanley boosted their price target on shares of Synopsys from $510.00 to $550.00 and gave the stock an “overweight” rating in a research note on Friday, December 12th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Synopsys in a report on Thursday, January 22nd. Finally, Bank of America upgraded Synopsys from an “underperform” rating to a “neutral” rating and dropped their price objective for the company from $525.00 to $500.00 in a report on Monday, December 8th. Nine equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Synopsys has an average rating of “Moderate Buy” and a consensus price target of $553.57.

About Synopsys

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.